Wegovy Semaglutide Pill Reaches Australia on Prescription
The Wegovy weight-loss tablet is reaching Australian pharmacies as a daily alternative to the weekly injection. Patients will need a private prescription and pay the full pharmacy price, with recommended monthly prices ranging from $260 to $395 depending on the dose.

The Wegovy semaglutide pill is reaching Australian pharmacies on private prescription, offering a daily alternative to the weekly weight-loss injection. Novo Nordisk recommends prices of $260 to $395 for a month's supply, depending on the dose, and patients will pay the full pharmacy price.
Chemistworks in Wetherill Park, in western Sydney, was among the first Australian pharmacies to receive stock. Pharmacist Catherine Bronger said supplies could take several days to reach some pharmacies.
“There will be varying prices depending on what pharmacy you go to and varying availability over the next week,” Bronger said.
Prices vary by dose
Novo Nordisk's recommended monthly price starts at $260 and reaches $395 for the highest dose. The tablet is launching without a Pharmaceutical Benefits Scheme subsidy, and pharmacies may charge different prices.
| Dose | Recommended price for one month |
|---|---|
| Starting dose | $260 |
| 4mg | $270 |
| 9mg | $280 |
| Highest dose | $395 |
The tablet contains semaglutide, the same active ingredient as the weekly Wegovy injection. It mimics a hormone released by the gut after eating and helps regulate appetite.
Bronger said some patients were hesitant about injecting themselves. Sydney resident Suzanne Cairns, 50, obtained a prescription after considering picking up tablets in Scotland, where she plans to spend Christmas with family.
Eligibility and side effects
The pill is approved for weight management in adults with a body mass index of 30 or above. Adults with an index of 27 or above and at least one weight-related health condition are also eligible.
Body mass index is a measure used to assess weight relative to height. The tablet is prescribed alongside dietary changes and increased physical activity, with the dose raised gradually under medical supervision.
In separate clinical trials, adults taking the highest tablet dose lost about 14% of their body weight on average over one year. Those taking the standard 2.4mg weekly injection lost about 15% over 68 weeks.
Sydney general practitioner Dr. Anjali Didi said regular appointments help patients manage side effects and review their dose. “The current advice is that the side effects are similar to the injectables,” she said.
Nausea, vomiting and diarrhea were among the most commonly reported side effects in the tablet trial. Pancreatitis, an inflammation of the pancreas, is a more serious risk.
Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
Lifestyle · Food & HealthWhat Is Raynaud’s Syndrome? Why Fingers Turn White in the Cold
Lifestyle · Food & Health4 Ways Walking After Meals Helps Your Body, Doctors Say
Lifestyle · Food & Health4 Reasons to Eat Oatmeal, According to Nutrition Experts
Lifestyle7 Signs Your Social Battery Is Running Low (and Why You Keep Cancelling Plans)















